News
Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.
The Singapore International Commercial Court (SICC) has upheld a worldwide freeze on USD 730 million in assets owned by ...
(Reuters) -Eli Lilly launched the pre-filled injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
CNBC's Silvia Amaro takes a look at the rise and fall in Novo Nordisk shares.
This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...
Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...
19h
TipRanks on MSNNovo Nordisk’s Semaglutide Study: A Potential Breakthrough for Kidney Health
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk recently completed a clinical study ...
Forever chemicals —also known as per- and polyfluoroalkyl substances, or PFAs, that don’t break down, but linger in the ...
Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results